# Intranasal Remimazolam for Premedication in Pediatric Patient

> **NCT04720963** · PHASE4 · COMPLETED · sponsor: **Second Affiliated Hospital of Wenzhou Medical University** · enrollment: 90 (actual)

## Conditions studied

- Sedative; Anxiety Disorder

## Interventions

- **DRUG:** Remimazolam
- **OTHER:** Distilled water for injection
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT04720963
- **Lead sponsor:** Second Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-07
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04720963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04720963, "Intranasal Remimazolam for Premedication in Pediatric Patient". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04720963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*